Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)

NCT01976741 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Rogaratinib (BAY1163877) oral solution
DRUG: Rogaratinib (BAY1163877) oral tablet
DRUG: Rogaratinib (BAY1163877) 800 mg BID

Sponsor

Bayer